论文部分内容阅读
目的:研究分析冠心病心绞痛患者接受倍他乐克、通心络联合治疗的临床效果。方法:根据2011年1月至2015年1月该院的128例冠心病心绞痛患者来进行研究分析,将这些患者分组为对照组和观察组各64例,对照组采取常规治疗,观察组使用常规治疗和倍他乐克、通心络联合治疗,对两组患者的临床治疗情况进行对比分析。结果:经过治疗后,观察组的临床治疗有效率是92.19%,对照组的治疗有效率是68.75%;对比两组的心电图改善情况,观察组的改善有效率是87.50%,对照组的改善有效率是75.00%,两组结果对比存在统计学差异(P<0.05)。结论:冠心病心绞痛疾病临床中使用常规治疗结合倍他乐克、通心络联合治疗的效果突出,临床中有效率高,患者的心电图改善明显,可以进行推广使用。
Objective: To study the clinical effect of combination of Betaloc and Tongxinluo in patients with coronary heart disease and angina pectoris. Methods: According to the analysis of 128 cases of CHD patients with angina pectoris in our hospital from January 2011 to January 2015, the patients were divided into control group and observation group, 64 cases in each group. The control group was treated routinely, and the observation group used conventional Treatment and Betaloc, Tongxinluo combined treatment, the clinical treatment of two groups were compared. Results: After treatment, the effective rate of clinical treatment was 92.19% in the observation group and 68.75% in the control group. Compared with the improvement of the electrocardiogram in the two groups, the improvement rate in the observation group was 87.50%, while that in the control group The efficiency was 75.00%, there was a significant difference between the two groups (P <0.05). Conclusion: The clinical treatment of coronary heart disease with angina pectoris combined with metoprolol, Tongxinluo combined treatment of outstanding results, the clinical high efficiency, the patient’s ECG improved significantly, can be promoted.